Skip to main content
OpenTrials
Completed

NCT Number: NCT00000188

Selegiline in Treatment of Cocaine Dependence - 2

The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

PDVAMC Treatment Research Center

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Selegiline

Drug

Primary outcomes

  1. Retention

  2. Cocaine use

  3. Cocaine craving

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Selegiline in Treatment of Cocaine Dependence

Important dates

Study start
1994
Primary completion
1995
Study completion
1995
First posted
Sep 21, 1999
Registry last updated
May 28, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.